AAAAAA

   
Results: 1-25 | 26-42 |
Results: 26-42/42
THE INHIBITION OF LYMPHOKINE-ACTIVATED KILLER-CELLS IN ACUTE MYELOBLASTIC-LEUKEMIA IS MEDIATED BY TRANSFORMING GROWTH FACTOR-BETA(1)
Authors: BERGMANN L SCHUI DK BRIEGER J WEIDMANN E MITROU PS HOELZER D
Citation: L. Bergmann et al., THE INHIBITION OF LYMPHOKINE-ACTIVATED KILLER-CELLS IN ACUTE MYELOBLASTIC-LEUKEMIA IS MEDIATED BY TRANSFORMING GROWTH FACTOR-BETA(1), Experimental hematology, 23(14), 1995, pp. 1574-1580
AML BLASTS VARIABLY EXPRESS INTERLEUKIN-2 RECEPTOR-ALPHA-CHAINS, BETA-CHAINS OR GAMMA-CHAINS WITHOUT MEASURABLE EFFECTS ON PROLIFERATION, CYTOKINE MESSAGE EXPRESSION OR SURFACE EXPRESSION OF ADHESION MOLECULESUPON STIMULATION WITH INTERLEUKIN-2
Authors: WEIDMANN E BRIEGER J BERGMANN L HOELZER D MITROU PS
Citation: E. Weidmann et al., AML BLASTS VARIABLY EXPRESS INTERLEUKIN-2 RECEPTOR-ALPHA-CHAINS, BETA-CHAINS OR GAMMA-CHAINS WITHOUT MEASURABLE EFFECTS ON PROLIFERATION, CYTOKINE MESSAGE EXPRESSION OR SURFACE EXPRESSION OF ADHESION MOLECULESUPON STIMULATION WITH INTERLEUKIN-2, Leukemia research, 19(7), 1995, pp. 469-476
BONE-MARROW-DERIVED T-CELL CLONES OBTAINED FROM UNTREATED ACUTE MYELOCYTIC-LEUKEMIA EXHIBIT BLAST DIRECTED AUTOLOGOUS CYTOTOXICITY
Authors: JAHN B BERGMANN L WEIDMANN E BRIEGER J FENCHEL K SCHWULERA U HOELZER D MITROU PS
Citation: B. Jahn et al., BONE-MARROW-DERIVED T-CELL CLONES OBTAINED FROM UNTREATED ACUTE MYELOCYTIC-LEUKEMIA EXHIBIT BLAST DIRECTED AUTOLOGOUS CYTOTOXICITY, Leukemia research, 19(2), 1995, pp. 73-82
EXPRESSION OF THE WILMS-TUMOR GENE (WT-1) IN ACUTE MYELOCYTIC-LEUKEMIA (AML) - CLINICAL AND FUNCTIONAL FEATURES
Authors: WEIDMANN E BRIEGER J MIETHING CC MAURER U BERGMANN L HOELZER D MITROU PS
Citation: E. Weidmann et al., EXPRESSION OF THE WILMS-TUMOR GENE (WT-1) IN ACUTE MYELOCYTIC-LEUKEMIA (AML) - CLINICAL AND FUNCTIONAL FEATURES, Blood, 86(10), 1995, pp. 155-155
INTERLEUKIN-2 (IL2) IN THE MAINTENANCE THERAPY OF 2ND REMISSION OF AML - BASIS AND CLINICAL-RESULTS
Authors: BERGMANN L WEIDMANN E SCHUI D HEIL G LENGFELDER E MITROU PS HOELZER D
Citation: L. Bergmann et al., INTERLEUKIN-2 (IL2) IN THE MAINTENANCE THERAPY OF 2ND REMISSION OF AML - BASIS AND CLINICAL-RESULTS, Blood, 86(10), 1995, pp. 2987-2987
THE EXPRESSION OF THE WILMS-TUMOR GENE IN ACUTE MYELOCYTIC LEUKEMIAS AS A POSSIBLE MARKER FOR LEUKEMIC BLAST CELLS
Authors: BRIEGER J WEIDMANN E FENCHEL K MITROU PS HOELZER D BERGMANN L
Citation: J. Brieger et al., THE EXPRESSION OF THE WILMS-TUMOR GENE IN ACUTE MYELOCYTIC LEUKEMIAS AS A POSSIBLE MARKER FOR LEUKEMIC BLAST CELLS, Leukemia, 8(12), 1994, pp. 2138-2143
FLUDARABINE IS AN EFFECTIVE AGENT IN IMMUNOCYTIC LYMPHOMA
Authors: FENCHEL K WIJERMANS P MITROU PS HOELZER D BERGMANN L
Citation: K. Fenchel et al., FLUDARABINE IS AN EFFECTIVE AGENT IN IMMUNOCYTIC LYMPHOMA, Onkologie, 17(5), 1994, pp. 508-513
IN-VIVO REGULATION OF TRANSFORMING GROWTH-FACTOR-BETA-1 TRANSCRIPTIONBY IMMUNOTHERAPY - INTERLEUKIN-2 IMPAIRS INTERFERON-ALPHA-STIMULATED INCREASE IN STEADY-STATE MESSENGER-RNA LEVELS OF TRANSFORMING GROWTH-FACTOR-BETA-1
Authors: JAHN B BRIEGER J FENCHEL K MITROU PS BERGMANN L
Citation: B. Jahn et al., IN-VIVO REGULATION OF TRANSFORMING GROWTH-FACTOR-BETA-1 TRANSCRIPTIONBY IMMUNOTHERAPY - INTERLEUKIN-2 IMPAIRS INTERFERON-ALPHA-STIMULATED INCREASE IN STEADY-STATE MESSENGER-RNA LEVELS OF TRANSFORMING GROWTH-FACTOR-BETA-1, Cancer immunology and immunotherapy, 38(5), 1994, pp. 304-310
RISK-ADAPTED TREATMENT OF HIV-RELATED HIGH-GRADE NON-HODGKINS-LYMPHOMAS WITH CHOP FOLLOWED BY IFN-ALPHA MAINTENANCE THERAPY
Authors: KNAUF W WEISS R NERL C SCHURMANN D VANLUNZEN J MITROU PS HUHN D
Citation: W. Knauf et al., RISK-ADAPTED TREATMENT OF HIV-RELATED HIGH-GRADE NON-HODGKINS-LYMPHOMAS WITH CHOP FOLLOWED BY IFN-ALPHA MAINTENANCE THERAPY, Blood, 84(10), 1994, pp. 10000163-10000163
IMMUNOSUPPRESSIVE EFFECTS AND CLINICAL-RESPONSE OF FLUDARABINE IN REFRACTORY CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: BERGMANN L FENCHEL K JAHN B MITROU PS HOELZER D
Citation: L. Bergmann et al., IMMUNOSUPPRESSIVE EFFECTS AND CLINICAL-RESPONSE OF FLUDARABINE IN REFRACTORY CHRONIC LYMPHOCYTIC-LEUKEMIA, Annals of oncology, 4(5), 1993, pp. 371-375
TRANSFORMING GROWTH-FACTOR TRANSCRIPTION AND RELEASE BY AML BLAST CELLS MAY INDICATE AN IMMUNOSUPPRESSIVE POTENTIAL
Authors: BRIEGER J JAHN B FENCHEL K WEIDMANN E MITROU PS BERGMANN L
Citation: J. Brieger et al., TRANSFORMING GROWTH-FACTOR TRANSCRIPTION AND RELEASE BY AML BLAST CELLS MAY INDICATE AN IMMUNOSUPPRESSIVE POTENTIAL, Experimental hematology, 21(8), 1993, pp. 1046-1046
HIGH EXPRESSION OF ICAM-1 ON LEUKEMIC-CELLS AND UP-REGULATION OF ITS LIGANDS ON LYMPHOCYTES BY IL-2 IN PATIENTS WITH AML
Authors: FENCHEL K BRIEGER J WEIDMANN E MITROU PS BERGMANN L HOELZER D
Citation: K. Fenchel et al., HIGH EXPRESSION OF ICAM-1 ON LEUKEMIC-CELLS AND UP-REGULATION OF ITS LIGANDS ON LYMPHOCYTES BY IL-2 IN PATIENTS WITH AML, Experimental hematology, 21(8), 1993, pp. 1115-1115
INVERSION OF REMISSION DURATION IN 2ND REMISSION OF AML BY INTERLEUKIN-2 - THE ANTILEUCEMIC EFFECT MAY BE PREDOMINANTLY CAUSED BY AUTOLOGOUS CD4-CYTOTOXIC LYMPHOCYTES()
Authors: BERGMAN L JAHN B HEIL G KOLBE K LENGFELDER E LOHMEYER J FENCHEL K WEIDMANN E MITROU PS HOELZER D
Citation: L. Bergman et al., INVERSION OF REMISSION DURATION IN 2ND REMISSION OF AML BY INTERLEUKIN-2 - THE ANTILEUCEMIC EFFECT MAY BE PREDOMINANTLY CAUSED BY AUTOLOGOUS CD4-CYTOTOXIC LYMPHOCYTES(), Experimental hematology, 21(8), 1993, pp. 1119-1119
DAILY ALTERNATING ADMINISTRATION OF HIGH-DOSE INTERFERON-ALPHA-2B ANDINTERLEUKIN-2 BOLUS INFUSION IN METASTATIC RENAL-CELL CANCER - A PHASE-II STUDY
Authors: BERGMANN L FENCHEL K WEIDMANN E ENZINGER HM JAHN B JONAS D MITROU PS
Citation: L. Bergmann et al., DAILY ALTERNATING ADMINISTRATION OF HIGH-DOSE INTERFERON-ALPHA-2B ANDINTERLEUKIN-2 BOLUS INFUSION IN METASTATIC RENAL-CELL CANCER - A PHASE-II STUDY, Cancer, 72(5), 1993, pp. 1733-1742
INTERFERON-ALPHA AND INTERLEUKIN-2 IN THE TREATMENT OF METASTATIC MELANOMA - COMPARISON OF 2 PHASE-II TRIALS
Authors: KEILHOLZ U SCHEIBENBOGEN C TILGEN W BERGMANN L WEIDMANN E SEITHER E RICHTER M BRADO B MITROU PS HUNSTEIN W
Citation: U. Keilholz et al., INTERFERON-ALPHA AND INTERLEUKIN-2 IN THE TREATMENT OF METASTATIC MELANOMA - COMPARISON OF 2 PHASE-II TRIALS, Cancer, 72(2), 1993, pp. 607-614
PROGNOSTIC VALUE OF SIMULTANEOUS EXPRESSION OF CD7 AND CD33 ON LEUKEMIC BLASTS IN AML UNFAVORABLE OUTCOME OF PATIENTS WITH CD54+ BLASTS
Authors: FENCHEL K BERGMANN L CHRIST S WEIDMANN E BRIEGER J MITROU PS HOELZER D
Citation: K. Fenchel et al., PROGNOSTIC VALUE OF SIMULTANEOUS EXPRESSION OF CD7 AND CD33 ON LEUKEMIC BLASTS IN AML UNFAVORABLE OUTCOME OF PATIENTS WITH CD54+ BLASTS, Blood, 82(10), 1993, pp. 10000122-10000122
INTERLEUKIN-2 CONSOLIDATION THERAPY IN PATIENTS WITH 2ND REMISSION OFDE-NOVO ACUTE MYELOCYTIC-LEUKEMIA - RESULTS OF A MULTICENTER TRIAL
Authors: BERGMANN L FENCHEL K HEIL G KOLBE K LENGFELDER E BRUCHER J LOHMEYER J MITROU PS HOELZER D
Citation: L. Bergmann et al., INTERLEUKIN-2 CONSOLIDATION THERAPY IN PATIENTS WITH 2ND REMISSION OFDE-NOVO ACUTE MYELOCYTIC-LEUKEMIA - RESULTS OF A MULTICENTER TRIAL, Blood, 82(10), 1993, pp. 10000130-10000130
Risultati: 1-25 | 26-42 |